|
1
|
Wang CH, Yao H, Chen LN, Jia JF, Wang L,
Dai JY, Zheng ZH, Chen ZN and Zhu P: CD147 induces angiogenesis
through a vascular endothelial growth factor and hypoxia-inducible
transcription factor 1α-mediated pathway in rheumatoid arthritis.
Arthritis Rheum. 64:1818–1827. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scott DL, Wolfe F and Huizinga TW:
Rheumatoid arthritis. Lancet. 376:1094–1108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kingsley G, Scott IC and Scott DL: Quality
of life and the outcome of established rheumatoid arthritis. Best
Pract Res Clin Rheumatol. 25:585–606. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kerola AM, Kauppi MJ, Nieminen T,
Rantalaiho V, Kautiainen H, Kerola T, Virta LJ, Pohjolainen T and
Puolakka K: Psychiatric and cardiovascular comorbidities as causes
of long-term work disability among individuals with recent-onset
rheumatoid arthritis. Scand J Rheumatol. 44:87–92. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Greisen SR, Rasmussen TK,
Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Hvid M and
Deleuran B: Increased soluble programmed death-1 (sPD-1) is
associated with disease activity and radiographic progression in
early rheumatoid arthritis. Scand J Rheumatol. 43:101–108. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li S, Liao W, Chen M, Shan S, Song Y,
Zhang S, Song H and Yuan Z: Expression of programmed death-1 (PD-1)
on CD4+ and CD8+ T cells in rheumatoid arthritis. Inflammation.
37:116–121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin YT, Wang CT, Gershwin ME and Chiang
BL: The pathogenesis of oligoarticular/polyarticular vs systemic
juvenile idiopathic arthritis. Autoimmun Rev. 10:482–489. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Coffey G, DeGuzman F, Inagaki M, Pak Y,
Delaney SM, Ives D, Betz A, Jia ZJ, Pandey A, Baker D, et al:
Specific inhibition of spleen tyrosine kinase suppresses leukocyte
immune function and inflammation in animal models of rheumatoid
arthritis. J Pharmacol Exp Ther. 340:350–359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Porter DL, Levine BL, Kalos M, Bagg A and
June CH: Chimeric antigen receptor-modified T cells in chronic
lymphoid leukemia. N Engl J Med. 365:725–733. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arpaia N, Campbell C, Fan X, Dikiy S, van
der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ and
Rudensky AY: Metabolites produced by commensal bacteria promote
peripheral regulatory T-cell generation. Nature. 504:451–455. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haile ST, Dalal SP, Clements V, Tamada K
and Ostrand-Rosenberg S: Soluble CD80 restores T cell activation
and overcomes tumor cell programmed death ligand 1-mediated immune
suppression. J Immunol. 191:2829–2836. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ceeraz S, Hall C, Choy EH, Spencer J and
Corrigall VM: Defective CD8+CD28+ regulatory T cell suppressor
function in rheumatoid arthritis is restored by tumour necrosis
factor inhibitor therapy. Clin Exp Immunol. 174:18–26. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dai S, Jia R, Zhang X, Fang Q and Huang L:
The PD-1/PD-Ls pathway and autoimmune diseases. Cell Immunol.
290:72–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bertsias GK, Nakou M, Choulaki C,
Raptopoulou A, Papadimitraki E, Goulielmos G, Kritikos H,
Sidiropoulos P, Tzardi M, Kardassis D, et al: Genetic, immunologic,
and immunohistochemical analysis of the programmed death
1/programmed death ligand 1 pathway in human systemic lupus
erythematosus. Arthritis Rheum. 60:207–218. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kay J and Upchurch KS: ACR/EULAR 2010
rheumatoid arthritis classification criteria. Rheumatology
(Oxford). 51:(Suppl 6). vi5–9. 2012.PubMed/NCBI
|
|
16
|
MPN, . World medical association publishes
the revised declaration of Helsinki. Natl Med J India.
27:562014.
|
|
17
|
Kralj JG, Munson MS and Ross D: Total
protein quantitation using the bicinchoninic acid assay and
gradient elution moving boundary electrophoresis. Electrophoresis.
35:1887–1892. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boissier MC, Assier E, Biton J, Denys A,
Falgarone G and Bessis N: Regulatory T cells (Treg) in rheumatoid
arthritis. Joint Bone Spine. 76:10–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heo YJ, Joo YB, Oh HJ, Park MK, Heo YM,
Cho ML, Kwok SK, Ju JH, Park KS, Cho SG, et al: IL-10 suppresses
Th17 cells and promotes regulatory T cells in the CD4+ T cell
population of rheumatoid arthritis patients. Immunol Lett.
127:150–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Woo SR, Turnis ME, Goldberg MV, Bankoti J,
Selby M, Nirschl CJ, Bettini ML, Gravano DM, Vogel P, Liu CL, et
al: Immune inhibitory molecules LAG-3 and PD-1 synergistically
regulate T-cell function to promote tumoral immune escape. Cancer
Res. 72:917–927. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pedoeem A, Azoulay-Alfaguter I, Strazza M,
Silverman GJ and Mor A: Programmed death-1 pathway in cancer and
autoimmunity. Clin Immunol. 153:145–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Curran MA, Montalvo W, Yagita H and
Allison JP: PD-1 and CTLA-4 combination blockade expands
infiltrating T cells and reduces regulatory T and myeloid cells
within B16 melanoma tumors. Proc Natl Acad Sci USA. 107:4275–4280.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pen JJ, Keersmaecker BD, Heirman C,
Corthals J, Liechtenstein T, Escors D, Thielemans K and Breckpot K:
Interference with PD-L1/PD-1 co-stimulation during antigen
presentation enhances the multifunctionality of antigen-specific T
cells. Gene Ther. 21:262–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fife BT, Pauken KE, Eagar TN, Obu T, Wu J,
Tang Q, Azuma M, Krummel MF and Bluestone JA: Interactions between
PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop
signal. Nat Immunol. 10:1185–1192. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen LS, Wang J, Shen DF, Yuan XL, Dong P,
Li MX, Xue J, Zhang FM, Ge HL and Xu D: CD4(+)CD25(+)CD127(low/−)
regulatory T cells express Foxp3 and suppress effector T cell
proliferation and contribute to gastric cancers progression. Clin
Immunol. 131:109–118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiao Z, Wang W, Jia R, Li J, You H, Chen L
and Wang Y: Accumulation of FoxP3-expressing CD4+CD25+ T cells with
distinct chemokine receptors in synovial fluid of patients with
active rheumatoid arthritis. Scand J Rheumatol. 36:428–433. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rico MC, Rough JJ, Del Carpio-Cano FE,
Kunapuli SP and Cadena RA DeLa: The axis of thrombospondin-1,
transforming growth factor beta and connective tissue growth
factor: An emerging therapeutic target in rheumatoid arthritis.
Curr Vasc Pharmacol. 8:338–343. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Checker R, Sandur SK, Sharma D, Patwardhan
RS, Jayakumar S, Kohli V, Sethi G, Aggarwal BB and Sainis KB:
Potent anti-inflammatory activity of ursolic acid, a triterpenoid
antioxidant, is mediated through suppression of NF-κB, AP-1 and
NF-AT. PloS One. 7:e313182012. View Article : Google Scholar : PubMed/NCBI
|
